Apotex Pays $24.1M, Enters Deferred Prosecution Pact For Drug Price Conspiracy

(May 11, 2020, 2:26 PM EDT) -- PHILADELPHIA — Generic drug manufacturer Apotex Corp. on May 7 agreed to pay a $24.1 million penalty and to enter into a deferred prosecution agreement with the U.S. Justice Department for...
To view the full article, register now.